- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Du Pont to sell in vitro diagnostics unit
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of Wilmington,DE.
The sale is part of Du Pont's plan to divest its Medical Productsbusinesses in order to pay for the repurchase of stock from Seagram(SCAN 6/7/95). The sale does not involve Du Pont's medical imagingfilm and PACS operations, however. Du Pont expects to announcea buyer for those businesses in the next four to six weeks.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
